x

Aug 17, 2026

Crown Bioscience Launches Standalone Global Workday Platform to Support Future Growth

July 16, 2026

Crown Bioscience Joins C-Path's NAMs Developer Coalition to Advance Human-Relevant Models in Drug Development

April 21, 2026

Crown Bioscience and Turbine Partner to Connect AI-Driven Prediction with Organoid Validation in Translational Oncology

April 16, 2026

AACR 2026: Crown Bioscience Showcases Integrated Platforms Enabling Next-Generation Oncology Modalities, Including ADCs and Radiopharmaceuticals

 
  • CrownLink
  • Databases
  • English
  • Deutsch
Crown Bioscience
  • Our Services
    Oncology & IO Solutions
    Preclinical Services
    Patient-Derived Translational Oncology
    Biomarker & Bioanalysis Services
    Clinical Biomarker Services
    Bioinformatics & Data Solutions
    Therapeutic Modalities
    ADCs
    Cell & Gene Therapy
    Radiopharmaceuticals
    Cancer Indications
    AML / Liquid Tumors
    Breast Cancer
    Prostate Cancer
    Pancreatic Cancer Drug Development
    Drug Targets
    KRAS
    EGFR
    IO Targets
    PARP
    Drug Resistance
    Drug Combinations
    Drug Discovery
    Target Discovery & Validation
    Drug Screening
    Efficacy
    Pharmacology
    In Silico Solutions
    Consulting
    In Vitro Services
    Cell Lines & Panels
    Cancer Cell Panel Screening
    Patient-derived Organoids
    Organoid Xplore
    Drug Screening & Combination Analysis
    Complex IO Assays
    High Content Imaging
    DMPK / Tox
    In Vivo DMPKT
    Bioanalysis
    Engineered Models & Services
    Target KO & CRISPR
    In Vivo Services
    PDX Models
    CDX Models
    Syngeneic Models
    Humanized GEMMs
    Tumor Homografts
    Humanized Models
    (HSC & PBMC)
    Orthotopic / Metastatic &
    Imaging-enabled Models
    Imaging Technology
    Digital Pathology
    High Content Imaging
    NAMs
    Patient Derived Systems
    PDX Mouse Clinical Trials
    Organoid and Matched PDX
    Ex Vivo Patient Tissue
    3D Bone Marrow Models
    Biomarker Discovery Services
    Cancer Cell Panel Screening
    Organoid Xplore
    PDX Mouse Clinical Trials
    Spatial Biology &
    Tissue-based Biomarker Analysis
    Histology & Immunostaining
    (H&E, IHC, IF, mIF)
    NanoString GeoMx
    10x Genomics Visium
    Tumor Tissue Microarrays
    Digital Pathology
    Protein Analysis
    Immunoassays
    (ELISA, MSD, Luminex)
    Flow Cytometry
    Mass Spec-proteomics
    Discovery Proteomics
    PTM Proteomics & Phosphoproteomics
    Rare Cell Analysis
    DNA / RNA Analysis
    Standard Genomics
    Next Generation Sequencing
    Single Cell Sequencing
    NanoString nCounter
    Optical Genome Mapping
    Mouse I/O RNA-seq Panel
    Microbiome Sequencing
    NanoString GeoMx
    10x Genomics Visium
    Cell Line Authentication
    Model-derived Biobank
    Tumor Tissue Microarrays
    Immune Monitoring
    Bioanalysis
    Biofluid Testing
    Regulatory Information
    Specialty Biomarker Services
    Clinical Biomarkers
    Biobanking Services
    Preclinical Cancer Model Databases
    Drug Combinations
    Bioinformatics Consulting
    Preclinical Biomarker Discovery
    Omics Data Analysis
    • Oncology & IO Solutions
        Therapeutic Modalities
        ADCs
        Cell & Gene Therapy
        Radiopharmaceuticals
        Cancer Indications
        AML / Liquid Tumors
        Breast Cancer
        Prostate Cancer
        Pancreatic Cancer Drug Development
        Drug Targets
        KRAS
        EGFR
        IO Targets
        PARP
        Drug Resistance
        Drug Combinations
        Drug Discovery
        Target Discovery & Validation
        Drug Screening
        Efficacy
        Pharmacology
        In Silico Solutions
        Consulting
    • Preclinical Services
        In Vitro Services
        Cell Lines & Panels
        Cancer Cell Panel Screening
        Patient-derived Organoids
        Organoid Xplore
        Drug Screening & Combination Analysis
        Complex IO Assays
        High Content Imaging
        DMPK / Tox
        In Vivo DMPKT
        Bioanalysis
        Engineered Models & Services
        Target KO & CRISPR
        In Vivo Services
        PDX Models
        CDX Models
        Syngeneic Models
        Humanized GEMMs
        Tumor Homografts
        Humanized Models
        (HSC & PBMC)
        Orthotopic / Metastatic &
        Imaging-enabled Models
        Imaging Technology
        Digital Pathology
        High Content Imaging
        NAMs
    • Patient-Derived Translational Oncology
        Patient Derived Systems
        PDX Mouse Clinical Trials
        Organoid and Matched PDX
        Ex Vivo Patient Tissue
        3D Bone Marrow Models
        Biomarker Discovery Services
        Cancer Cell Panel Screening
        Organoid Xplore
        PDX Mouse Clinical Trials
    • Biomarker & Bioanalysis Services
        Spatial Biology &
        Tissue-based Biomarker Analysis
        Histology & Immunostaining
        (H&E, IHC, IF, mIF)
        NanoString GeoMx
        10x Genomics Visium
        Tumor Tissue Microarrays
        Digital Pathology
        Protein Analysis
        Immunoassays
        (ELISA, MSD, Luminex)
        Flow Cytometry
        Mass Spec-proteomics
        Discovery Proteomics
        PTM Proteomics & Phosphoproteomics
        Rare Cell Analysis
        DNA / RNA Analysis
        Standard Genomics
        Next Generation Sequencing
        Single Cell Sequencing
        NanoString nCounter
        Optical Genome Mapping
        Mouse I/O RNA-seq Panel
        Microbiome Sequencing
        NanoString GeoMx
        10x Genomics Visium
        Cell Line Authentication
        Model-derived Biobank
        Tumor Tissue Microarrays
        Immune Monitoring
        Bioanalysis
        Biofluid Testing
    • Clinical Biomarker Services
        Regulatory Information
        Specialty Biomarker Services
        Clinical Biomarkers
        Biobanking Services
    • Bioinformatics & Data Solutions
        Preclinical Cancer Model Databases
        Drug Combinations
        Bioinformatics Consulting
        Preclinical Biomarker Discovery
        Omics Data Analysis
  • Publications & Resources
    Blog
    Podcast
    Publications
    Resources
      Blog
      Podcast
      Publications
      Resources
  • About Us
    Company
    Leadership & SAB
    News & Events
    Careers
    Awards & Testimonials
    Regulatory Information
      Company
      Leadership & SAB
      News & Events
      Careers
      Awards & Testimonials
      Regulatory Information
  • CrownLink
  • Databases
Contact Us
Contact Us
  • English
  • Deutsch
  • There are no suggestions because the search field is empty.

CVMD

    Dec 12, 2025
    Why Integrating DMPK with Biomarker Strategies Improves Predictive Power (test)
    Learn More
    Sep 10, 2024
    Sample Post 1
    Learn More
    Aug 31, 2024
    Sample Post 2
    Learn More
    Jul 1, 2024
    Sample Post 4
    Learn More
    1 2 Next
    • Oncology & I/O Solutions
      • Therapeutic Modalities
      • Drug Targets
      • Cancer Indications
      • Drug Discovery
    • Preclinical Services
      • In Vitro Services
      • In Vivo Services
      • DMPK / Tox
      • Imaging Technology
      • Engineered Models & Services
      • NAMs
    • Patient-Derived Translational Oncology
      • Patient Derived Systems
      • Biomarker Discovery Services
    • Biomarker & Bioanalysis Services
      • Spatial Biology & Tissue-based Biomarker Analysis
      • DNA / RNA Analysis
      • Protein Analysis
      • Immune Monitoring
      • Bioanalysis
      • Biofluid Testing
    • Clinical Biomarker & Biospecimen Services
      • Regulatory Accreditations
      • Clinical Biomarkers
      • Specialty Biomarker Services
    • Bioinformatics & Data Solutions
      • Preclinical Cancer Model Databases
      • Preclinical Biomarker Discovery
      • Drug Combinations
      • Omics Data Analysis
      • Bioinformatics Consulting
    Crown Bioscience
    © 2026 Crown Bioscience. All Rights Reserved.
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms of Service
    • Privacy Preferences
    • ACA Form 1095-C
    linkedin-black
    Twitter-black